Measuring Progress Beyond the Scales
How to track progress on GLP-1 treatment beyond body weight: waist-to-height ratio, blood pressure, blood tests, fitness, strength, sleep and wellbeing.
On this page
Measuring weight loss progress on GLP-1 treatment works well when you look beyond the scales. Body weight is useful, but it fluctuates and doesn't show changes in fat, muscle or health. Combining regular weighing with a waist measurement, health markers such as blood pressure and blood tests, and practical measures like fitness, strength, sleep and wellbeing gives a fuller and fairer picture. This is particularly helpful during plateaus. This guide explains which measures matter, how to take them accurately, and how to discuss them with your prescriber.
Why the scales aren't the whole story
The bathroom scales measure everything at once: fat, muscle, bone, organs, water and the contents of your gut. Day-to-day changes are dominated by water and food, not fat. This means:
- Weight can rise by a kilogram or more overnight after a salty meal, a hard workout, or around menstruation.
- Constipation, which is a common side effect of GLP-1 medicines, can temporarily add weight.
- Building or preserving muscle through strength exercise can offset fat loss on the scales.
- Weight doesn't tell you about blood pressure, blood glucose, fitness or wellbeing.
Weight is still the main measure used in trials and by prescribers, and tracking it matters. But on its own it can be misleading, especially during the plateaus that are a normal part of treatment. See our guide to weight loss plateaus on GLP-1 medication.
Weighing yourself well
Consistency matters
To get readings you can compare:
- Weigh at the same time of day, ideally in the morning after using the toilet and before eating or drinking.
- Wear similar clothing, or none.
- Use the same scales, on a hard, flat floor.
- Record the reading in a notebook or app.
How often?
There is no single right answer. Some people prefer weekly weighing; others weigh daily and look at a weekly average, which smooths out fluctuations. If weighing causes anxiety or obsessive thoughts, it is reasonable to weigh less often and focus on other measures.
Percentage change
Calculating your weight change as a percentage of your starting weight makes it easier to compare your progress with trial results and with NICE's review point. To calculate it: (starting weight − current weight) ÷ starting weight × 100.
For example, someone starting at 110 kg who now weighs 99 kg has lost 11 kg, which is 10% of their starting weight.
NICE guidance for NHS treatment with semaglutide (TA875) and tirzepatide (TA1026) uses 5% weight loss after six months on the highest tolerated dose as a point to review treatment. See our guide to realistic weight loss expectations.
Waist measurement and waist-to-height ratio
Why waist matters
Fat stored around the abdomen, particularly around internal organs, is closely linked to type 2 diabetes, heart disease and other conditions. Waist measurement is a simple way to track it. It can fall even when weight is stable.
In SURMOUNT-5, the head-to-head trial of tirzepatide and semaglutide, average waist circumference fell by about 18 cm with tirzepatide and about 13 cm with semaglutide over 72 weeks, showing how much this measure can change on treatment.
How to measure
NHS guidance suggests:
- Find the bottom of your ribs and the top of your hips.
- Wrap a tape measure around your waist midway between these points. For many people, this is roughly in line with the belly button.
- Breathe out naturally before measuring.
- Keep the tape snug but not digging in.
- Measure at the same time of day, under the same conditions, each time.
Measuring every two to four weeks is usually enough to see a trend.
Waist-to-height ratio
NICE guidance recommends that adults with a BMI under 35 use waist-to-height ratio alongside BMI to assess health risks linked to central fat. The message is simple: keep your waist measurement to less than half your height.
| Waist-to-height ratio | What it indicates |
|---|---|
| 0.4 to 0.49 | No increased health risk |
| 0.5 to 0.59 | Increased health risk |
| 0.6 or more | High health risk |
To calculate it, divide your waist by your height, using the same units. For example, a waist of 90 cm and a height of 170 cm gives a ratio of about 0.53.
Other measurements
Some people also track hip, chest, thigh or upper arm measurements. These can help show changes in body shape. Taking photos in similar lighting and clothing every few months is another option, if you find it helpful.
BMI: useful, but limited
Body mass index (BMI) is calculated from weight and height. It is used to decide eligibility for weight-loss medicines and to classify weight in adults. You can calculate yours using our BMI calculator.
BMI has well-known limitations:
- It doesn't distinguish between fat and muscle.
- It doesn't show where fat is stored.
- Risk at a given BMI differs between ethnic groups, which is why lower thresholds are used for some people. See our guide to BMI thresholds and ethnicity.
As your weight changes, your BMI will fall too. It is a useful summary, but waist-to-height ratio and health markers add important detail. Read more in our guide to BMI and treatment eligibility.
Health markers
For many people, the most important benefits of weight loss show up in health measures rather than on the scales.
| Marker | How it's measured | What often happens with weight loss |
|---|---|---|
| Blood pressure | Home monitor, pharmacy or GP | Often falls; blood pressure medicines may need adjusting |
| HbA1c (average blood glucose) | Blood test via GP | Often improves; diabetes medicines may need reducing |
| Cholesterol and triglycerides | Blood test via GP | Triglycerides in particular often improve |
| Liver tests | Blood test via GP | Fatty liver markers may improve |
| Kidney function | Blood test via GP | Should be checked if dehydration occurs |
| Resting heart rate | Monitor or wearable | GLP-1 medicines can slightly increase resting heart rate; tell your prescriber about palpitations |
Home blood pressure
A validated, upper-arm home blood pressure monitor can help track changes. Measure at the same time of day, seated and rested, and record several readings. If you take blood pressure medicines and notice dizziness or readings becoming low, speak to your GP or pharmacist, as doses may need adjusting.
Blood tests
Blood tests are arranged by your GP or prescriber when clinically appropriate. If you have type 2 diabetes, high cholesterol or fatty liver disease, ask whether repeat tests are planned. Improvements in these markers can be meaningful even when weight loss is modest.
The SELECT trial
The SELECT trial showed that semaglutide 2.4 mg reduced major cardiovascular events by about 20% in people with established heart disease and overweight or obesity, with average weight loss of around 10%. Research suggests that some of this benefit may not be explained by weight loss alone. This is a reminder that health outcomes matter as much as weight. See our guide to Wegovy and the SELECT trial.
Body composition
Fat versus muscle
All weight loss includes some lean mass, which includes muscle, alongside fat. Body composition studies within STEP 1 and SURMOUNT-1 found that most of the weight lost on semaglutide and tirzepatide was fat, but lean mass made up a meaningful minority. Preserving muscle supports strength, metabolism, balance and long-term health, particularly as you get older.
How body composition is measured
| Method | Where | Notes |
|---|---|---|
| DEXA (DXA) scan | Hospitals, research, some private clinics | Accurate; not routinely available for this purpose on the NHS |
| Bioelectrical impedance (smart scales) | Home | Convenient, but readings vary with hydration, meals and exercise |
| Skinfold callipers | Some gyms or clinics | Depends heavily on the skill of the person measuring |
| Waist and other measurements | Home | Simple, practical, and correlates with abdominal fat |
For most people, a combination of weight, waist and strength measures gives enough information without specialist tests.
Fitness, strength and function
Improvements in what your body can do are some of the most motivating signs of progress, and they support long-term health.
Measures you can track at home
- Walking. How far or how long you can walk comfortably, or your average daily steps.
- Stairs. Whether you can climb a flight without stopping or getting breathless.
- Strength. The number of sit-to-stand repetitions from a chair in 30 seconds, or the weight you can lift in a particular exercise.
- Balance and flexibility. Standing on one leg, or reaching your toes.
- Everyday tasks. Carrying shopping, gardening, playing with children or grandchildren.
UK physical activity guidelines recommend at least 150 minutes of moderate activity a week and strength exercises on at least two days. Tracking progress against these can help. See our guides on exercise on GLP-1 medication and strength training for beginners.
Sleep, energy and wellbeing
Weight loss can bring improvements in sleep, energy, mood and confidence, though not for everyone.
- Sleep. Snoring and obstructive sleep apnoea often improve with weight loss. Tirzepatide has been studied specifically in sleep apnoea; see our guide to tirzepatide and sleep apnoea.
- Energy. Some people feel more energetic, although eating less can cause tiredness, especially early on.
- Pain. Knee, hip and back pain may ease.
- Mood and confidence. Many people report feeling more confident, but changes in body image and relationships with food can also be complicated.
- Food noise. Many people report fewer intrusive thoughts about food on GLP-1 medicines.
A simple weekly rating out of ten for energy, sleep, mood and pain can show patterns over time.
Putting it together: a simple tracking plan
| Measure | Suggested frequency |
|---|---|
| Weight | Weekly (or daily with weekly average) |
| Waist | Every 2–4 weeks |
| Waist-to-height ratio | Monthly |
| Blood pressure (if monitored at home) | As advised by your GP or pharmacist |
| Blood tests | As arranged by your GP or prescriber |
| Fitness and strength test | Monthly |
| Energy, sleep, mood and pain rating | Weekly |
| Side effects | As they occur, and at each review |
| Medicine and dose changes | Each time they happen |
Bringing this information to reviews helps your prescriber make informed decisions about your dose and treatment. It is also useful if you ever need to change provider; see our guide to switching providers mid-treatment.
Using your records in reviews
When you speak to your prescriber, it helps to share:
- Your percentage weight change since starting
- Your waist measurement trend
- Any changes in blood pressure or blood test results
- Side effects and how you're managing them
- How you're eating, including protein and fluids
- Changes in activity, strength and wellbeing
Good providers will ask about more than just weight. You can compare the follow-up and support offered by regulated services on our providers page, and see how service costs compare on our prices page.
For more on results and progress, explore our results topic hub and the wider guides library.
Common tracking pitfalls
Tracking progress is useful, but some habits can make it misleading or stressful.
Reacting to single readings
A rise of a kilogram overnight is almost always water, food or bowel contents, not fat. Looking at averages over several weeks gives a much more accurate picture.
Changing the conditions
Weighing at different times of day, after meals, in different clothes or on different scales can create apparent changes that aren't real. Consistency matters more than precision.
Measuring waist at different points
Moving the tape measure up or down by a few centimetres can change the reading noticeably. Use the same landmarks each time, and consider marking the position in your notes.
Relying on smart scale body-fat numbers
Home body-composition readings can swing by several percentage points with changes in hydration. Treat them as rough trends at most.
Only tracking what's going wrong
It is easy to focus on stalls and setbacks. Make a point of noting improvements too, such as walking further, sleeping better, reduced medication or improved blood results.
Tracking too much
Recording every meal, measurement and number every day can become overwhelming. Choose a few measures that matter to you and track them at sensible intervals.
Progress milestones that matter
Health benefits often appear at different points. While individual experiences vary, research suggests that:
| Weight loss | Benefits that may be seen in many people |
|---|---|
| 5% | Improvements in blood pressure, blood glucose and triglycerides; reduced risk of developing type 2 diabetes in people at high risk |
| 10% | Further improvements in these markers; improvements in fatty liver, sleep apnoea and joint pain for many people |
| 15% or more | Greater improvements across a range of conditions; for some people with type 2 diabetes, improvements large enough to reduce medicines |
These are general patterns, not predictions of what any individual will experience. Your GP or prescriber can tell you which changes are most relevant to your health.
Tracking tools
You don't need specialist equipment to track progress. Useful tools include:
- A notebook or simple spreadsheet for weights, measurements and notes
- A flexible tape measure for waist and other measurements
- A validated upper-arm blood pressure monitor, if your GP recommends home monitoring
- A step counter or phone app, if you find this motivating
- The NHS App, which can give access to some of your GP records and test results, depending on your practice
Whatever you use, consistency matters more than sophistication. Keep your records somewhere you can easily share them with your prescriber or a new provider if needed.
When to speak to a professional
Speak to your prescriber, GP or pharmacist if:
- Your weight or waist measurement has stopped changing for several months and you want to review your plan
- You are losing weight very quickly, or feel weak, dizzy or faint
- Your home blood pressure readings are consistently high or low, or you feel dizzy on standing
- You have diabetes and your blood glucose readings are falling low
- You notice palpitations or a persistently fast heartbeat
- Tracking is causing distress, or you are worried about your relationship with food
Seek urgent medical help (NHS 111, or 999 in an emergency) if you have:
- Severe, persistent abdominal pain, which may spread to your back, with or without vomiting
- Pain in the upper right abdomen with fever, or yellowing of the skin or eyes
- Repeated vomiting or diarrhoea with signs of dehydration
- Symptoms of very low blood sugar, such as confusion, sweating or shaking, if you take insulin or a sulfonylurea
- Chest pain, or a sudden change in vision
Frequently asked questions
Sources
- Overweight and obesity management (NG246). National Institute for Health and Care Excellence, 2025.
- Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes (SELECT). New England Journal of Medicine, 2023.
- Tirzepatide as Compared with Semaglutide for the Treatment of Obesity (SURMOUNT-5). New England Journal of Medicine, 2025.
- Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). New England Journal of Medicine, 2021.
- Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). New England Journal of Medicine, 2022.
- Tirzepatide for managing overweight and obesity (TA1026). National Institute for Health and Care Excellence, 2024.
- Physical activity guidelines for adults aged 19 to 64. NHS, 2024.
Written by
Our editorial team researches UK weight management medicines and regulated online providers, working from primary sources such as SmPCs, NICE guidance and peer-reviewed trials.
This article has not yet been reviewed by a registered clinician. Read our editorial policy to see how clinical review works.
Related guides
Results and evidence Realistic Weight Loss Expectations on GLP-1 Treatment
How much weight people lose on Mounjaro, Wegovy and GLP-1 tablets in trials, how results vary, the typical timeline and what affects your own outcome.
12 min read
Plateaus Weight Loss Plateaus on GLP-1 Medication
Why weight loss slows or stalls on Mounjaro or Wegovy, what trials show about plateaus, and the practical and clinical options to discuss with a prescriber
12 min read
Eligibility BMI Explained: How It Decides Treatment Eligibility
What BMI is, how it is calculated, its limitations, and how BMI thresholds decide eligibility for weight loss injections privately and on the NHS.
12 min read